Granulocyte colony-stimulating factor plus plerixafor

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Lymphoma, Non-HodgkinMultiple Myeloma

Phase 3

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

CompletedNCT00103610

Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin

Start: 2005-01-31End: 2007-12-31Updated: 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

CompletedNCT00103662

Genzyme, a Sanofi CompanyMultiple Myeloma

Start: 2005-01-31End: 2008-01-31Updated: 2014-03-13

Related Papers

Cost-Effectiveness Analysis of Motixafortide Versus Plerixafor in Stem Cell Mobilization for Autologous Transplantation in Patients with Multiple Myeloma

Blood2022-11-151 citations

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

2009-04-10596 citations